GSK Investigational Site

Zion, Illinois 60099

0 studies enrolling now · 6 studies all time

What they study most

Neoplasms, Neoplasms, Breast, Ovarian Neoplasms, Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma, Relapsed Breast Cancer

Studies at this site

• A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer — Running, not enrolling
• A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer — Running, not enrolling
• Study Of Lapatinib In Combination With Paclitaxel In The Treatment Of Newly Diagnosed Inflammatory Breast Cancer — Completed
• Study Of Lapatinib In Patients With Relapsed Or Refractory Inflammatory Breast Cancer — Completed
• Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer — Completed
• Lapatinib In Combination With Chemotherapy In Subjects With Relapsed Breast Cancer — Stopped early